CECI, FRANCESCO
CECI, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
How to Report {PSMA} {PET}
2024 M. Swiha, N. Ayati, D.E. Oprea-Lager, F. Ceci, L. Emmett
Comparison of different algorithms for the conversion of RTSS file into binary mask for SPECT-based 177Lu-peptide kidney dosimetry: impact on kidneys’ volume and absorbed dose
2023 G. Castiglione Minischetti, M.E. Ferrari, D. Alio, A. Barone, F. Ceci, C.M. Grana, F. Botta
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma]
2023 L. Lavinia Travaini, F. Botta, E. Derenzini, G. Lo Presti, M. Esmeralda Ferrari, L. Simona Air(`(o)) Farulla, T. Radice, S. Mazzara, C. Tarella, S. Pileri, S. Raimondi, F. Ceci
Automatic Segmentation with Deep Learning in Radiotherapy
2023 L. Isaksson, P. Summers, F. Mastroleo, G. Marvaso, G. Corrao, M. Vincini, M. Zaffaroni, F. Ceci, G. Petralia, R. Orecchia, B. Jereczek-Fossa
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature
2023 G. Piperno, A. Ferrari, S. Volpe, F. Cattani, M. Zaffaroni, S. Comi, F. Pansini, L. Bergamaschi, G.C. Mazzola, F. Ceci, M. Colandrea, G. Petralia, R. Orecchia, B.A. Jereczek-Fossa, D. Alterio
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
2023 S. Mazzara, L. Travaini, F. Botta, C. Granata, G. Motta, F. Melle, S. Fiori, V. Tabanelli, A. Vanazzi, S. Ramadan, T. Radice, S. Raimondi, G. Lo Presti, M.E. Ferrari, B.A. Jereczek-Fossa, C. Tarella, F. Ceci, S. Pileri, E. Derenzini
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives
2023 L. Muraglia, F. Mattana, G. Zuccotti, F. Collamati, S. Luzzago, L.L. Travaini, G. Musi, F. Ceci
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
2023 L. Bianchi, F. Ceci, F. Costa, E. Balestrazzi, M. Droghetti, P. Piazza, A. Pissavini, R. Mei, A. Farolfi, P. Castellucci, S. Puliatti, A. Larcher, G. Gandaglia, D. Robesti, A. Mottrie, A. Briganti, A.G. Morganti, S. Fanti, F. Montorsi, R. Schiavina, E. Brunocilla
First Live-Experience Session with PET/CT Specimen Imager: A pilot analysis in Prostate Cancer and Neuroendocrine Tumor
2023 L. Muraglia, F. Mattana, L.L. Travaini, G. Musi, E. Bertani, G. Renne, E. Pisa, M.E. Ferrari, U. Fumagalli Romario, O. De Cobelli, N. Fusco, F. Ceci
{PSMA} {PET}/{CT}: joint {EANM} procedure guideline/{SNMMI} procedure standard for prostate cancer imaging 2.0
2023 W.P. Fendler, M. Eiber, M. Beheshti, J. Bomanji, J. Calais, F. Ceci, S.Y. Cho, S. Fanti, F.L. Giesel, K. Goffin, U. Haberkorn, H. Jacene, P.J. Koo, K. Kopka, B.J. Krause, L. Lindenberg, C. Marcus, F.M. Mottaghy, D.E. Oprea-Lager, J.R. Osborne, M. Piert, S.P. Rowe, H. Schöder, S. Wan, H. Wester, T.A. Hope, K. Herrmann
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review
2023 F. Mattana, L. Muraglia, P. Raiwa, F. Zattoni, G. Marra, P.K.F. Chiu, I. Heidegger, V. Kasivisvanathan, C.V. Kesch, J. Olivier, F. Preisser, C. Thibault, M. Valerio, R.C.N. van den Bergh, G. Gandaglia, F. Ceci
Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy
2022 C. Zamboglou, I. Strouthos, J. Sahlmann, A. Farolfi, F. Serani, F. Medici, L. Cavallini, A.G. Morganti, C. Trapp, S.A. Koerber, J.C. Peeken, M.M.E. Vogel, K. Schiller, S.E. Combs, M. Eiber, A. Vrachimis, K. Ferentinos, S.K.B. Spohn, S. Kirste, C. Gratzke, J. Ruf, A.-. Grosu, F. Ceci, W.P. Fendler, J. Miksch, S. Kroeze, M. Guckenberger, H. Lanzafame, S. Fanti, G. Hruby, T. Wiegel, L. Emmett, N.S. Schmidt-Hegemann, C. Henkenberens
Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay
2022 L.S. Airo Farulla, E. Demirci, P. Castellucci, N. Alan-Selcuk, E. Fortunati, L. Gilardi, F. Ceci
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
2022 S.K.B. Spohn, A. Farolfi, S. Schandeler, M.M.E. Vogel, J. Ruf, M. Mix, S. Kirste, F. Ceci, S. Fanti, H. Lanzafame, F. Serani, C. Gratzke, A. Sigle, S.E. Combs, D. Bernhardt, J.E. Gschwend, J.A. Buchner, C. Trapp, C. Belka, P. Bartenstein, L. Unterrainer, M. Unterrainer, M. Eiber, S.G. Nekolla, K. Schiller, A.L. Grosu, N.-. Schmidt-Hegemann, C. Zamboglou, J.C. Peeken
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
2022 L. Gilardi, L. Simona Airò Farulla, E. Demirci, I. Clerici, E. Omodeo Salè, F. Ceci
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
2022 F. Ceci, G. Rovera, G. Carlo Iorio, A. Guarneri, V. Chiofalo, R. Passera, M. Oderda, S. Dall’Armellina, V. Liberini, S. Grimaldi, M. Bello’, P. Gontero, U. Ricardi, D. Deandreis
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence
2021 L. Bianchi, P. Castellucci, A. Farolfi, M. Droghetti, C. Artigas, J. Leite, P. Corona, Q. Ahmed Shagera, R. Moreira, C. Gonz('(a))lez, M. Queiroz, F. de Galiza Barbosa, R. Schiavina, D. Deandreis, S. Fanti, F. Ceci
Diagnostic Accuracy of Ga-68-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection A Multicenter Prospective Phase 3 Imaging Trial
2021 T.A. Hope, M. Eiber, W.R. Armstrong, R. Juarez, V. Murthy, C. Lawhn-Heath, S.C. Behr, L. Zhang, F. Barbato, F. Ceci, A. Farolfi, S.M. Schwarzenböck, M. Unterrainer, H.D. Zacho, H.G. Nguyen, M.R. Cooperberg, P.R. Carroll, R.E. Reiter, S. Holden, K. Herrmann, S. Zhu, W.P. Fendler, J. Czernin, J. Calais
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas
2021 R. Laudicella, N. Quartuccio, G. Argiroffi, P. Alongi, L. Baratto, E. Califaretti, V. Frantellizzi, G. De Vincentis, A. Del Sole, L. Evangelista, S. Baldari, S. Bisdas, F. Ceci, A. Iagaru
Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
2021 F. Ceci, G. Musi, O. De Cobelli